Tsukasa Sanada

541 total citations
13 papers, 491 citations indexed

About

Tsukasa Sanada is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Tsukasa Sanada has authored 13 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Tsukasa Sanada's work include Hormonal Regulation and Hypertension (7 papers), Renin-Angiotensin System Studies (5 papers) and Synthesis of Tetrazole Derivatives (2 papers). Tsukasa Sanada is often cited by papers focused on Hormonal Regulation and Hypertension (7 papers), Renin-Angiotensin System Studies (5 papers) and Synthesis of Tetrazole Derivatives (2 papers). Tsukasa Sanada collaborates with scholars based in Japan and United States. Tsukasa Sanada's co-authors include Takeo Wada, Yumiko Shibouta, Keiji Kubo, Kohei Nishikawa, Mami Ojima, Yasuhisa Kohara, Yasuhiro Inada, Takehiko Naka, M Ojima and Yoshiyuki Inada and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, European Journal of Pharmacology and Bioorganic & Medicinal Chemistry.

In The Last Decade

Tsukasa Sanada

13 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tsukasa Sanada Japan 9 345 215 197 46 45 13 491
M Ojima Japan 6 302 0.9× 167 0.8× 166 0.8× 35 0.8× 41 0.9× 9 409
R S Chang United States 9 284 0.8× 240 1.1× 135 0.7× 54 1.2× 33 0.7× 9 478
P C Wong United States 8 343 1.0× 294 1.4× 181 0.9× 73 1.6× 42 0.9× 10 579
Wieslawa Maniara Switzerland 9 235 0.7× 142 0.7× 176 0.9× 16 0.3× 77 1.7× 15 532
Alain Roccon France 10 254 0.7× 169 0.8× 96 0.5× 47 1.0× 21 0.5× 21 454
Pierre Schiavi France 14 311 0.9× 125 0.6× 119 0.6× 26 0.6× 67 1.5× 23 557
Thomas L. Waldron United States 12 190 0.6× 177 0.8× 91 0.5× 46 1.0× 33 0.7× 25 473
Michael E. Beil Switzerland 12 144 0.4× 125 0.6× 149 0.8× 36 0.8× 31 0.7× 28 447
M. Dubar France 10 318 0.9× 75 0.3× 126 0.6× 44 1.0× 98 2.2× 16 536
Holger Heitsch Germany 13 436 1.3× 277 1.3× 229 1.2× 37 0.8× 123 2.7× 20 756

Countries citing papers authored by Tsukasa Sanada

Since Specialization
Citations

This map shows the geographic impact of Tsukasa Sanada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsukasa Sanada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsukasa Sanada more than expected).

Fields of papers citing papers by Tsukasa Sanada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsukasa Sanada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsukasa Sanada. The network helps show where Tsukasa Sanada may publish in the future.

Co-authorship network of co-authors of Tsukasa Sanada

This figure shows the co-authorship network connecting the top 25 collaborators of Tsukasa Sanada. A scholar is included among the top collaborators of Tsukasa Sanada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsukasa Sanada. Tsukasa Sanada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Imaeda, Yasuhiro, Michiko Tawada, Mitsuyo Kondo, et al.. (2016). Structure-based design of a new series of N-(piperidin-3-yl)pyrimidine-5-carboxamides as renin inhibitors. Bioorganic & Medicinal Chemistry. 24(22). 5771–5780. 11 indexed citations
2.
Ogino, Masaki, Nobuyuki Negoro, Shigekazu Itokawa, et al.. (2011). Discovery of a Novel Acyl-CoA: Cholesterol Acyltransferase Inhibitor: The Synthesis, Biological Evaluation, and Reduced Adrenal Toxicity of (4-Phenylcoumarin)acetanilide Derivatives with a Carboxylic Acid Moiety. Chemical and Pharmaceutical Bulletin. 59(11). 1369–1375. 3 indexed citations
3.
Ogino, Masaki, Ryosuke Tokunoh, Shigekazu Itokawa, et al.. (2011). Discovery of a Potent and Orally Available Acyl-CoA: Cholesterol Acyltransferase Inhibitor as an Anti-atherosclerotic Agent: (4-Phenylcoumarin)acetanilide Derivatives. Chemical and Pharmaceutical Bulletin. 59(10). 1268–1273. 6 indexed citations
4.
Ojima, Mami, Yoshiyuki Inada, Yumiko Shibouta, et al.. (1997). Candesartan (CV-11974) dissociates slowly from the angiotensin AT1 receptor. European Journal of Pharmacology. 319(1). 137–146. 122 indexed citations
5.
Wada, Takeo, et al.. (1997). Regional Hemodynamic Effects of Candesartan Cilexetil (TCV-116), an Angiotensin II AT1-Receptor Antagonist, in Conscious Spontaneously Hypertensive Rats.. The Japanese Journal of Pharmacology. 73(3). 185–190. 12 indexed citations
6.
Wada, Takeo, et al.. (1997). Regional Hemodynamic Effects of Candesartan Cilexetil (TCV-116), an Angiotensin II AT1-Receptor Antagonist, in Conscious Spontaneously Hypertensive Rats. The Japanese Journal of Pharmacology. 73(3). 185–190. 2 indexed citations
7.
Nishikawa, Kohei, Takehiko Naka, Masakuni Noda, et al.. (1996). Angiotensin II receptor antagonistic action of candesartan (CV-11974) in the rabbit aorta. 24(10). 121–126. 2 indexed citations
8.
9.
10.
Shibouta, Yumiko, Fumio Chatani, Y Ishimura, et al.. (1996). TCV-116 inhibits renal interstitial and glomerular injury in glomerulosclerotic rats.. PubMed. 55. S115–8. 10 indexed citations
11.
Wada, Takeo, et al.. (1994). Effect of an angiotensin II receptor antagonist, CV-11974, and its prodrug, TCV-116, on production of aldosterone. European Journal of Pharmacology. 253(1-2). 27–34. 27 indexed citations
12.
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Ojima Breakdown of academic impact, for papers by R S Chang Breakdown of academic impact, for papers by P C Wong Breakdown of academic impact, for papers by Wieslawa Maniara Breakdown of academic impact, for papers by Alain Roccon Breakdown of academic impact, for papers by Pierre Schiavi Breakdown of academic impact, for papers by Thomas L. Waldron Breakdown of academic impact, for papers by Michael E. Beil Breakdown of academic impact, for papers by M. Dubar Breakdown of academic impact, for papers by Holger Heitsch
Rankless by CCL
2026